ATLAS / Macro Radar / Reporting / PTHS

Pelthos Therapeutics Inc. (PTHS) reporting calendar

Pelthos Therapeutics Inc. files periodic reports with the SEC as PTHS on NYSE. Atlas tracks 10 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
23 Jul 2026 – 3 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
10

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open PTHS market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll NYSE reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001919246-26-000070
10-K31 Dec 202519 Mar 202678 days0001919246-26-000013
10-Q30 Sep 202513 Nov 202544 days0001753926-25-001764
10-Q30 Jun 202513 Aug 202544 days0001753926-25-001326
10-Q31 Mar 202513 May 202543 days0001753926-25-000790
10-K31 Dec 202427 Mar 202586 days0001753926-25-000503
10-Q30 Sep 202413 Nov 202444 days0001753926-24-001883
10-Q30 Jun 202413 Aug 202444 days0001753926-24-001423
10-Q31 Mar 202415 May 202445 days0001753926-24-000976
10-K31 Dec 202316 Apr 2024107 days0001753926-24-000740

Source: SEC EDGAR company submissions for CIK 0001919246. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.